personalized medicine: pharmacogenomics and drug development

نویسندگان

somayeh mirsadeghi endocrinology and metabolism research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, iran.

bagher larijani diabetes research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, iran.

چکیده

personalized medicine aims is to supply the proper drug to the proper patient within the right dose. pharmacogenomics (pgx) is to recognize genetic variants that may influence drug efficacy and toxicity. all things considered, the fields cover a wide area, including basic drug discovery researches, the genetic origin of pharmacokinetics and pharmacodynamics, novel drug improvement, patient genetic assessment and clinical patient administration. at last, the objective of pharmacogenomics is to anticipate a patient’s genetic response to a particular drug as a way of presenting the best possible medical treatment. by predicting the drug response of an individual, it will be possible to increase the success of therapies and decrease the incidence of adverse side effect.

Sign up for free to access the full text

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
acta medica iranica

جلد ۵۵، شماره ۳، صفحات ۱۵۰-۱۶۵

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023